STOCK TITAN

Byline Bancorp (BY) Financials

BY
Trailing 12 months to June 30, 2026
Revenue $462.9M +10.2% YoY
Net Income $149.5M +25.6% YoY
EPS (Diluted) $3.32 +24.3% YoY
Free Cash Flow $162.3M +46.0% YoY
Market Cap $1.7B as of Sep 10, 2026
Price / Sales 3.7x on $462.9M revenue, trailing 12 months to June 30, 2026
Price / Earnings 11.6x on $149.5M net income, trailing 12 months to June 30, 2026
Price / Book 1.3x on $1.3B equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 10, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the BY SEC filings page.

Byline Bancorp (BY) reported $462.9M in revenue over the twelve months to Jun 30, 2026, up 10.2% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 11 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI BY FY2025

Byline’s bank-style earnings growth is paired with falling leverage, but a larger equity base is diluting returns.

FY2025 net income rose while operating cash flow fell, so reported earnings converted less generously into cash than in FY2024. Because free cash flow stayed close to operating cash flow$136M versus $140M—the shortfall was not mainly a capital-spending burden; it points to weaker cash generation before reinvestment.

Equity increased by $176M while liabilities edged down, taking debt-to-equity to 6.6x. ROE fell to 10.3% from 11.1%, showing the larger capital base diluted returns even as leverage improved.

Revenue and net income rose through FY2025, but net margin remained in a narrow band around 28%30%, indicating scale has not materially altered the bank’s earnings economics. Revenue growth outpaced selling, general and administrative expense growth, yet net margin eased to 29.2% from 29.7%; the benefit was partly absorbed elsewhere in the income statement.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Earnings Growth Capital Efficiency CreditQuality Stability 59 / 100
Financial Health Score 59/100
Scored as: Banks peer group

Scored against banks for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Byline Bancorp's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Earnings
77

Byline Bancorp earned a return on assets of 1.4% in fiscal year 2025, which is the profit it made on every dollar of assets on its books. This is up from 1.3% the prior year. Earnings ranks banks on that return over three years, and Byline Bancorp scores 77/100 among other banks.

Growth
48

Byline Bancorp reported revenue of $446.3M in fiscal year 2025, against $406.9M in fiscal year 2024. Growth ranks banks on the three-year path of their net revenue, which is interest income and fee income less the interest they pay out, and Byline Bancorp scores 48/100 among other banks.

Capital
70

Byline Bancorp funded 13.1% of its assets with shareholders' equity at the end of fiscal year 2025, holding $1.3B of equity against $9.7B of assets. Capital ranks banks on that cushion, and Byline Bancorp scores 70/100 among other banks.

Efficiency
84

Efficiency measures what a bank spends running itself against the revenue that spending brings in, so a lower ratio is the better one. Byline Bancorp scores 84/100 on it among other banks.

Credit Quality
0

Not available for Byline Bancorp, and counted as zero in the overall score.

Stability
74

Byline Bancorp reported net income of $130.1M in fiscal year 2025, against $120.8M in fiscal year 2024. Stability ranks banks on how steady net income has been across five years, and Byline Bancorp scores 74/100 among other banks.

Piotroski F-Score Partial
5/6

Byline Bancorp passes 5 of 6 computable financial strength tests (3 of the nine could not be computed from available data). All 4 profitability signals pass (positive income, cash flow, and earnings quality), no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), both operating efficiency signals pass.

Earnings Quality Cash-Backed
1.08x

For every $1 of reported earnings, Byline Bancorp generates $1.08 in operating cash flow ($140.3M OCF vs $130.1M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$117.7M
YoY+6.6%
QoQ+4.7%
5Y CAGR+8.3%
10Y CAGR+16.0%

Byline Bancorp generated $117.7M in revenue in Q2 2026. This represents an increase of 6.6% from the same quarter a year earlier. Against the prior quarter it is up 4.7%.

Net Income
$40.2M
YoY+33.6%
QoQ+6.9%
5Y CAGR+7.1%
10Y CAGR+31.5%

Byline Bancorp reported $40.2M in net income in Q2 2026. This represents an increase of 33.6% from the same quarter a year earlier. Against the prior quarter it is up 6.9%.

EPS (Diluted)
$0.90
YoY+36.4%
QoQ+8.4%
5Y CAGR+4.3%
10Y CAGR+21.3%

Byline Bancorp earned $0.90 per diluted share (EPS) in Q2 2026. This represents an increase of 36.4% from the same quarter a year earlier. Against the prior quarter it is up 8.4%.

EBITDA

Not reported for Q2 2026.

Cash & Balance Sheet

Free Cash Flow
$13.2M
YoY-14.9%
QoQ-75.7%
5Y CAGR-24.1%

Byline Bancorp generated $13.2M in free cash flow in Q2 2026, representing cash available after capex. This represents a decrease of 14.9% from the same quarter a year earlier. Against the prior quarter it is down 75.7%.

Cash & Debt
$193.6M
YoY-11.4%
QoQ-2.4%
5Y CAGR+13.5%
10Y CAGR+12.4%

Byline Bancorp held $193.6M in cash as of Q2 2026; long-term debt is not reported for that period.

Dividends Per Share
$0.12
YoY+20.0%
QoQ0.0%
5Y CAGR+14.9%

Byline Bancorp paid $0.12 per share in dividends in Q2 2026. This represents an increase of 20.0% from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding
45M
YoY-1.5%
QoQ-0.5%
5Y CAGR+3.7%

Byline Bancorp had 45M shares outstanding in Q2 2026. This represents a decrease of 1.5% from the same quarter a year earlier. Against the prior quarter it is down 0.5%.

Margins & Returns

Net Margin
34.1%
YoY+6.9pp
QoQ+0.7pp
5Y CAGR-1.9pp
10Y CAGR+24.3pp

Byline Bancorp's net profit margin was 34.1% in Q2 2026, showing the share of revenue converted to profit. This is up 6.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.7 percentage points.

Return on Equity
3.1%
YoY+0.6pp
QoQ+0.1pp
5Y CAGR-0.4pp
10Y CAGR+2.0pp

Byline Bancorp's ROE was 3.1% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is up 0.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.1 percentage points.

Gross Margin

Not reported for Q2 2026.

Operating Margin

Not reported for Q2 2026.

Capital Allocation

Share Buybacks
$9.1M
YoY-30.9%
QoQ-7.7%
5Y CAGR-5.6%

Byline Bancorp spent $9.1M on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 30.9% from the same quarter a year earlier. Against the prior quarter it is down 7.7%.

Capital Expenditures
$1.0M
YoY-7.3%
QoQ+120.3%
5Y CAGR+8.9%

Byline Bancorp invested $1.0M in capex in Q2 2026, funding long-term assets and infrastructure. This represents a decrease of 7.3% from the same quarter a year earlier. Against the prior quarter it is up 120.3%.

R&D Spending

Not reported for Q2 2026.

BY Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BY quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Revenue$117.7M+6.6%$112.4M+9.0%$117.0M+11.8%$115.7M+13.6%$110.5M+11.2%$103.1M+2.0%$104.7M+3.9%$101.8M-2.9%
SG&A Expenses$35.7M-5.7%$36.2M0.0%$38.8M+4.1%$37.5M+7.2%$37.8M+11.5%$36.3M+6.8%$37.3M+16.6%$35.0M0.0%
Interest Expense$43.5M-10.5%$41.8M-10.4%$42.9M-15.9%$48.7M-17.4%$48.6M-11.8%$46.6M-11.6%$51.1M+3.5%$59.0M+33.6%
Income Tax$13.9M+57.0%$12.1M+31.1%$12.4M+23.6%$12.7M+31.0%$8.8M-15.3%$9.2M-8.9%$10.0M-3.1%$9.7M-2.0%
Net Income$40.2M+33.6%$37.6M+33.0%$34.6M+13.9%$37.2M+22.7%$30.1M+1.4%$28.2M-7.2%$30.4M+2.5%$30.3M+7.5%
EPS (Basic)$0.90+36.4%$0.84+29.2%$0.76+8.6%$0.82+17.1%$0.66-2.9%$0.65-7.1%$0.70+2.9%$0.70+6.1%
EPS (Diluted)$0.90+36.4%$0.83+29.7%$0.77+13.2%$0.82+18.8%$0.66-2.9%$0.64-8.6%$0.68-1.4%$0.69+6.2%
Diluted Shares (Avg)45M-1.5%45M+1.7%N/A45M+3.2%45M+4.0%44M+1.3%N/A44M+1.2%

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, R&D Expenses, Operating Income, EBITDA.

BY Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BY quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Total Assets$9.9B+2.2%$9.9B+3.4%$9.7B+1.6%$9.8B+4.1%$9.7B+0.9%$9.6B+1.9%$9.5B+6.9%$9.4B+5.4%
Cash & Equivalents$193.6M-11.4%$198.4M-52.9%$149.1M-73.5%$259.0M-42.8%$218.3M-70.1%$421.3M-33.8%$563.1M+149.0%$452.6M+5.5%
Short-Term Investments$0$0$0$0$0$0$0$0
Long-Term Investments$0$0$0$0$0$0$0$0
Goodwill$181.9M0.0%$181.9M+0.1%$181.9M+0.1%$181.9M+0.1%$181.9M+0.1%$181.7M0.0%$181.7M0.0%$181.7M0.0%
Total Liabilities$8.6B+1.2%$8.6B+2.1%$8.4B-0.2%$8.6B+3.0%$8.5B-0.8%$8.5B+0.6%$8.4B+6.5%$8.3B+3.8%
Total Equity$1.3B+9.4%$1.3B+13.2%$1.3B+16.2%$1.2B+12.9%$1.2B+15.4%$1.1B+12.1%$1.1B+10.2%$1.1B+19.2%
Retained Earnings$712.6M+22.2%$677.9M+21.5%$645.7M+20.9%$615.8M+21.3%$583.2M+21.2%$557.7M+22.4%$533.9M+24.4%$507.6M+25.8%

Not reported in any period shown, so not listed: Current Assets, Inventory, Accounts Receivable, Current Liabilities, Non-Current Liabilities, Long-Term Debt.

BY Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BY quarterly cash flow statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Cash Flow$14.2M-14.4%$54.6M+96.2%$58.6M+10.9%$37.3M+88.6%$16.5M-58.8%$27.8M-55.4%$52.9M+1164.9%$19.8M-74.8%
Depreciation & Amortization$1.1M-3.0%$1.1M-2.5%$1.1M-5.1%$1.1M-8.6%$1.1M-12.8%$1.2M-11.4%$1.2M-10.4%$1.2M-0.7%
Stock-Based CompensationN/A$2.2M+9.5%N/AN/AN/A$2.0M+8.7%N/AN/A
Capital Expenditures$1.0M-7.3%$458K-77.2%$516K-75.4%$381K-41.3%$1.1M+48.8%$2.0M+293.0%$2.1M+109.0%$649K-50.7%
Free Cash Flow$13.2M-14.9%$54.1M+109.7%$58.1M+14.5%$36.9M+93.0%$15.5M-60.8%$25.8M-58.3%$50.8M+950.5%$19.1M-75.2%
Investing Cash Flow-$29.9M-84.5%-$229.5M-5.3%$42.5M+22705.9%-$31.9M+31.4%-$16.2M+88.2%-$218.0M-48.6%-$188K+99.8%-$46.5M+65.6%
Financing Cash Flow$10.9M+105.4%$224.2M+356.9%-$211.1M-464.9%$34.3M+113.6%-$203.0M-206.3%$49.1M-90.1%$57.8M+158.6%-$251.1M-251.9%
Dividends Paid$5.7M+19.2%$5.4M+22.6%$4.5M+14.7%$4.5M+15.2%$4.8M+16.0%$4.4M+12.4%$3.9M+1.3%$3.9M-3.4%
Share Buybacks$9.1M-30.9%$9.8M+1328.2%$9.8M$193K$13.1M$687K$0$0

BY Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

BY quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Net Margin34.1%+6.9pp33.4%+6.0pp29.5%+0.5pp32.1%+2.4pp27.2%-2.6pp27.4%-2.7pp29.0%-0.4pp29.8%+2.9pp
Return on Equity3.1%+0.6pp2.9%+0.4pp2.7%0.0pp3.0%+0.2pp2.5%-0.3pp2.5%-0.5pp2.8%-0.2pp2.8%-0.3pp
Return on Assets0.4%+0.1pp0.4%+0.1pp0.4%0.0pp0.4%+0.1pp0.3%0.0pp0.3%0.0pp0.3%0.0pp0.3%0.0pp
Debt-to-Equity6.62-0.5x6.74-0.7x6.61-1.1x6.93-0.7x7.15-1.2x7.47-0.9x7.70-0.3x7.60-1.1x
Asset Turnover0.010.0x0.010.0x0.010.0x0.010.0x0.010.0x0.010.0x0.010.0x0.010.0x
FCF Margin11.2%-2.8pp48.1%+23.1pp49.7%+1.2pp31.9%+13.1pp14.0%-25.7pp25.0%-36.2pp48.5%+54.4pp18.8%-54.9pp

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Current Ratio.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Byline Bancorp BY FY2025 $446.3M $130.1M 29.1% $1.7B 59/100
National Bk Hldgs Corp NBHC FY2025 $416.1M $109.6M 26.3% $1.8B 53/100
Hope Bancorp HOPE FY2025 $498.7M $62.0M 12.4% $1.8B 34/100
DIME COMMERCIAL BANCSHARES INC DCOM FY2025 $452.9M $110.7M 24.4% $1.8B 37/100
Westamerica Bancorporation WABC FY2025 $258.1M $116.2M 45.0% $1.3B 70/100
Bank First Corp BFC FY2025 $173.9M $71.5M 41.1% $1.7B 69/100

Frequently Asked Questions

What is Byline Bancorp's annual revenue?

Byline Bancorp (BY) reported $446.3M in total revenue for fiscal year 2025. This represents a 9.7% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Byline Bancorp's revenue growing?

Byline Bancorp (BY) revenue grew by 9.7% year-over-year, from $406.9M to $446.3M in fiscal year 2025.

Is Byline Bancorp profitable?

Yes, Byline Bancorp (BY) reported a net income of $130.1M in fiscal year 2025, with a net profit margin of 29.1%.

Byline Bancorp (BY) reported diluted earnings per share of $2.89 for fiscal year 2025. This represents a 5.1% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Byline Bancorp (BY) had a net profit margin of 29.1% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, Byline Bancorp (BY) paid $0.40 per share in dividends during fiscal year 2025.

Byline Bancorp (BY) has a return on equity of 10.3% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Byline Bancorp (BY) generated $136.3M in free cash flow during fiscal year 2025. This represents a -20.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Byline Bancorp (BY) generated $140.3M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Byline Bancorp (BY) had $9.7B in total assets as of fiscal year 2025, including both current and long-term assets.

Byline Bancorp (BY) invested $4.0M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, Byline Bancorp (BY) spent $23.7M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Byline Bancorp (BY) had 46M shares outstanding as of fiscal year 2025.

Byline Bancorp (BY) had a debt-to-equity ratio of 6.61 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Byline Bancorp (BY) had a return on assets of 1.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Byline Bancorp (BY) trades at 11.6x earnings, its market capitalization divided by net income of $149.5M net income, trailing 12 months to June 30, 2026. The market capitalization is $1.7B as of Sep 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Byline Bancorp (BY) trades at 3.7x sales, its market capitalization divided by revenue of $462.9M revenue, trailing 12 months to June 30, 2026. The market capitalization is $1.7B as of Sep 10, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Byline Bancorp (BY) has a Piotroski F-Score of 5 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Byline Bancorp (BY) has an earnings quality ratio of 1.08x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Byline Bancorp (BY) scores 59 out of 100 on our Financial Health Score, indicating moderate standing within its banks peer group. The score is a 0-100 composite of six dimensions (Earnings, Growth, Capital, Efficiency, Credit Quality, Stability), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top